respiratory
Asthma

New safety review of montelukast leads to “risk mitigation activities”


Ongoing concerns about possible neuropsychiatric side effects of montelukast in children and adolescents have prompted the TGA to call for active education of parents and caregivers at the time of prescription of the leukotriene receptor antagonist for asthma. In a  safety alert the regulator has reminded health professionals – despite more than 20 years of its use ...

Already a member?

Enter your email to keep reading.


OR